The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 06, 2015

Filed:

Aug. 12, 2013
Applicant:

President and Fellows of Harvard College, Cambridge, MA (US);

Inventors:

Douglas A. Melton, Lexington, MA (US);

Malgorzata Borowiak, Somerville, MA (US);

Rene Maehr, Somerville, MA (US);

Shuibing C. Chen, Arlington, MA (US);

Weiping Tang, Madison, WI (US);

Julia L. Fox, Arlington, MA (US);

Stuart L. Schreiber, Boston, MA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/02 (2006.01); C07C 61/06 (2006.01); C07C 61/16 (2006.01); C07C 405/00 (2006.01); C12N 5/0735 (2010.01); C12N 5/073 (2010.01);
U.S. Cl.
CPC ...
C12N 5/0606 (2013.01); C12N 5/0603 (2013.01); C12N 2501/999 (2013.01); C12N 2506/02 (2013.01);
Abstract

Certain embodiments disclosed herein are directed to a method of producing endoderm cells, such as definitive endoderm cells by exposing stem cells such as embryonic stem cells or induced pluripotent stem (iPS) cells to an effective amount of at least one compound described herein to differentiate the stem cells into the endoderm cells such as definitive endoderm cells. Differentiated endoderm cells produced by the methods disclosed herein can be differentiated into pancreatic epithelium, and other endoderm derivatives such as thymus, liver, stomach, intestine and lung. Another aspect of the present invention relates to a method of producing pancreatic progenitor cells, such as Pdx1-positive pancreatic progenitor cells by exposing endoderm cells, such as definitive endoderm cells to an effective amount of at least one compound described herein to differentiate the definitive endoderm cells into Pdx1-positive pancreatic progenitor cells. Kits and compositions comprising Pdx1-positive pancreatic progenitor produced using the methods are also described.


Find Patent Forward Citations

Loading…